We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.6B
AUM Growth
+$1.31B
(+11%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
52.17%
Holding
753
New
79
Increased
425
Reduced
211
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$190M |
| 2 |
Enterprise Products Partners
EPD
|
+$96.4M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$94.8M |
| 4 |
Plains All American Pipeline
PAA
|
+$81.9M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$36.6M |
| 2 |
NOV
NOV
|
+$34.2M |
| 3 |
Qualcomm
QCOM
|
+$34.1M |
| 4 |
CenterPoint Energy
CNP
|
+$32.7M |
| 5 |
ConocoPhillips
COP
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.49% |
| 2 | Financials | 2.86% |
| 3 | Materials | 2.35% |
| 4 | Healthcare | 2.33% |
| 5 | Industrials | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
701
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $166K | ﹤0.01% |
34,307
-11,067
| -24% | -$329K |
|
702
Rocket Pharmaceuticals
RCKT
$348M
| $158K | ﹤0.01% |
6,470
-2,113
| -25% | -$60.3K |
|
703
Abercrombie & Fitch
ANF
$4.17B
| $153K | ﹤0.01% |
+12,750
| New | +$189K |
|
704
Oaktree Specialty Lending
OCSL
$1.03B
| $141K | ﹤0.01% |
+8,721
| New | +$145K |
|
|
OCSI
705
DELISTED
Oaktree Strategic Income Corporation
OCSI
| $141K | ﹤0.01% |
16,144
+5,461
| +51% | +$48.2K |
|
|
BKS
706
DELISTED
Barnes & Noble
BKS
| $130K | ﹤0.01% |
+11,689
| New | +$134K |
|
|
AKS
707
DELISTED
AK Steel Holding Corp
AKS
| $128K | ﹤0.01% |
+12,515
| New | +$95.2K |
|
|
S
708
DELISTED
Sprint Corporation
S
| $121K | ﹤0.01% |
14,396
+83
| +0.6% | +$614 |
|
|
FCRD
709
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $115K | ﹤0.01% |
+11,484
| New | +$112K |
|
710
Opko Health
OPK
$921M
| $93K | ﹤0.01% |
10,019
-4,176
| -29% | -$43.2K |
|
711
SiriusXM
SIRI
$10B
| $71K | ﹤0.01% |
1,584
-2,402
| -60% | -$105K |
|
712
Genworth Financial
GNW
$3.8B
| $48K | ﹤0.01% |
+12,633
| New | +$55.7K |
|
713
Nokia
NOK
$50.8B
| $48K | ﹤0.01% |
+10,026
| New | +$47.3K |
|
|
ODP
714
DELISTED
ODP
ODP
| $47K | ﹤0.01% |
1,045
-272
| -21% | -$11.3K |
|
715
Groupon
GRPN
$980M
| $46K | ﹤0.01% |
+699
| New | +$58.8K |
|
716
Alcoa
AA
$11.7B
| – | – |
-20,996
| Closed | -$486K |
|
717
Cincinnati Financial
CINF
$28.3B
| – | – |
-409,081
| Closed | -$30.9M |
|
|
718
ConocoPhillips
COP
$147B
| – | – |
-731,704
| Closed | -$31.8M |
|
719
Fortive
FTV
$19B
| – | – |
-261,214
| Closed | -$8.38M |
|
720
Hecla Mining
HL
$10.2B
| – | – |
-1,385,044
| Closed | -$7.89M |
|
721
Insmed
INSM
$23.2B
| – | – |
-78,884
| Closed | -$1.15M |
|
722
Larimar Therapeutics
LRMR
$416M
| – | – |
-2,903
| Closed | -$115K |
|
723
MetLife
MET
$61B
| – | – |
-790,430
| Closed | -$31.3M |
|
724
MediciNova
MNOV
$65M
| – | – |
-43,944
| Closed | -$329K |
|
|
725
NOV
NOV
$7.45B
| – | – |
-931,866
| Closed | -$34.2M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ALPS Advisors held 753 positions worth $13.6B, up 11% from $12.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ALPS Advisors deployed $1.24B of net new capital in Q4 2016, opening 79 new positions and adding to 425 existing holdings. Its largest new stake was Eli Lilly: 558,209 shares worth $41.1M.
By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Nucor, an estimated $36.6M trimmed.
- ALPS Advisors's largest Q4 2016 buy was Eli Lilly: 558,209 shares worth $41.1M.
- ALPS Advisors added most to Energy Transfer Partners L.p. in Q4 2016, an estimated $190M increase.
- ALPS Advisors's biggest Q4 2016 reduction was Nucor, cutting an estimated $36.6M.
- ALPS Advisors fully exited NOV in Q4 2016, selling an estimated $34.2M.
- ALPS Advisors's ten largest holdings make up 52% of its $13.6B portfolio in Q4 2016.
- ALPS Advisors opened 79 new positions and closed 38 in Q4 2016.
- ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $13.6B.
Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.